Which has stronger valuation & earnings, VCT or ZTF?

Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Victrex £296.40M 2.47 £30.80M -£22.40 N/A Zotefoams £176.29M 1.24 £9.80M £44.87 9.93

Is VCT or ZTF more profitable?

Zotefoams has a net margin of 13.88% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.18% beat Victrex's return on equity. Company Net Margins Return on Equity Return on Assets Victrex -6.70% -4.95% 6.59% Zotefoams 13.88% 18.18% 5.48%

Do analysts prefer ZTF or SCPA?

Zotefoams presently has a consensus target price of GBX 605, suggesting a potential upside of 35.80%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts clearly believe Zotefoams is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zotefoams 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, ZTF or TET?

Treatt has lower revenue, but higher earnings than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £176.29M 1.24 £9.80M £44.87 9.93 Treatt £128.29M 1.40 £11.22M £7.22 42.24

Is ZTF or TET more profitable?

Zotefoams has a net margin of 13.88% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.18% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 13.88% 18.18% 5.48% Treatt 3.40% 3.22% 6.72%

Which has stronger earnings & valuation, SYNT or ZTF?

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.80B 0.09 -£82.04M -£96.00 N/A Zotefoams £176.29M 1.24 £9.80M £44.87 9.93

Is SYNT or ZTF more profitable?

Zotefoams has a net margin of 13.88% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.18% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -6.81% -13.27% -0.28% Zotefoams 13.88% 18.18% 5.48%

Which has stronger earnings and valuation, ZTF or IOF?

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £176.29M 1.24 £9.80M £44.87 9.93 Iofina £66.52M 1.47 £4.28M £4.00 12.75

Is ZTF or IOF more profitable?

Zotefoams has a net margin of 13.88% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.18% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 13.88% 18.18% 5.48% Iofina 11.84% 14.89% 5.18%

Zotefoams (ZTF) Competitors

GBX 445.50 +5.50 (+1.25%)

As of 08/28/2026 12:04 PM Eastern

Compare

ZTF vs. VCT, SCPA, TET, SYNT, and IOF

Should you buy Zotefoams stock or one of its competitors? Zotefoams's main competitors and comparable companies include Victrex (VCT), Scapa Group (SCPA), Treatt (TET), Synthomer (SYNT), and Iofina (IOF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "specialty chemicals" industry.

How does Zotefoams compare to Victrex?

Victrex (LON:VCT) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Victrex currently has a consensus target price of GBX 663.33, indicating a potential downside of 21.13%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 35.80%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts plainly believe Zotefoams is more favorable than Victrex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Victrex	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Victrex has a beta of 0.812, meaning that its share price is 19% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.243, meaning that its share price is 24% more volatile than the broader market.

Zotefoams has a net margin of 13.88% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.18% beat Victrex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Victrex	-6.70%	-4.95%	6.59%
Zotefoams	13.88%	18.18%	5.48%

Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Victrex	£296.40M	2.47	£30.80M	-£22.40	N/A
Zotefoams	£176.29M	1.24	£9.80M	£44.87	9.93

In the previous week, Victrex had 2 more articles in the media than Zotefoams. MarketBeat recorded 2 mentions for Victrex and 0 mentions for Zotefoams. Victrex's average media sentiment score of 0.69 beat Zotefoams' score of 0.00 indicating that Victrex is being referred to more favorably in the media.

Company	Overall Sentiment
Victrex	Positive
Zotefoams	Neutral

Victrex pays an annual dividend of GBX 59.56 per share and has a dividend yield of 7.1%. Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.7%. Victrex pays out -265.9% of its earnings in the form of a dividend. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Victrex is clearly the better dividend stock, given its higher yield and lower payout ratio.

75.5% of Victrex shares are held by institutional investors. Comparatively, 28.9% of Zotefoams shares are held by institutional investors. 4.2% of Victrex shares are held by insiders. Comparatively, 4.5% of Zotefoams shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Victrex and Zotefoams tied by winning 9 of the 18 factors compared between the two stocks.

How does Zotefoams compare to Scapa Group?

Zotefoams (LON:ZTF) and Scapa Group (LON:SCPA) are both small-cap materials companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

Zotefoams presently has a consensus target price of GBX 605, suggesting a potential upside of 35.80%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts clearly believe Zotefoams is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Zotefoams has higher earnings, but lower revenue than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£176.29M	1.24	£9.80M	£44.87	9.93
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A

In the previous week, Zotefoams' average media sentiment score of 0.00 equaled Scapa Group'saverage media sentiment score.

Company	Overall Sentiment
Zotefoams	Neutral
Scapa Group	Neutral

28.9% of Zotefoams shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Zotefoams has a net margin of 13.88% compared to Scapa Group's net margin of 0.00%. Zotefoams' return on equity of 18.18% beat Scapa Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	13.88%	18.18%	5.48%
Scapa Group	N/A	N/A	N/A

Summary

Zotefoams beats Scapa Group on 10 of the 11 factors compared between the two stocks.

How does Zotefoams compare to Treatt?

Zotefoams (LON:ZTF) and Treatt (LON:TET) are both small-cap materials companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.7%. Treatt pays an annual dividend of GBX 5.60 per share and has a dividend yield of 1.8%. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Treatt pays out 77.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Zotefoams presently has a consensus price target of GBX 605, suggesting a potential upside of 35.80%. Treatt has a consensus price target of GBX 248.33, suggesting a potential downside of 18.58%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts plainly believe Zotefoams is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Zotefoams has a net margin of 13.88% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.18% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	13.88%	18.18%	5.48%
Treatt	3.40%	3.22%	6.72%

Treatt has lower revenue, but higher earnings than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£176.29M	1.24	£9.80M	£44.87	9.93
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24

In the previous week, Zotefoams' average media sentiment score of 0.00 equaled Treatt'saverage media sentiment score.

Company	Overall Sentiment
Zotefoams	Neutral
Treatt	Neutral

Zotefoams has a beta of 1.243, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Treatt has a beta of 0.907, indicating that its stock price is 9% less volatile than the broader market.

28.9% of Zotefoams shares are owned by institutional investors. Comparatively, 17.5% of Treatt shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 4.1% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Zotefoams beats Treatt on 11 of the 16 factors compared between the two stocks.

How does Zotefoams compare to Synthomer?

Synthomer (LON:SYNT) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

Synthomer has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Zotefoams has a beta of 1.243, suggesting that its share price is 24% more volatile than the broader market.

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A
Zotefoams	£176.29M	1.24	£9.80M	£44.87	9.93

Zotefoams has a net margin of 13.88% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.18% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Zotefoams	13.88%	18.18%	5.48%

14.9% of Synthomer shares are owned by institutional investors. Comparatively, 28.9% of Zotefoams shares are owned by institutional investors. 5.0% of Synthomer shares are owned by company insiders. Comparatively, 4.5% of Zotefoams shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Synthomer presently has a consensus price target of GBX 119, suggesting a potential upside of 19.36%. Zotefoams has a consensus price target of GBX 605, suggesting a potential upside of 35.80%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts plainly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Synthomer had 2 more articles in the media than Zotefoams. MarketBeat recorded 2 mentions for Synthomer and 0 mentions for Zotefoams. Synthomer's average media sentiment score of 0.32 beat Zotefoams' score of 0.00 indicating that Synthomer is being referred to more favorably in the media.

Company	Overall Sentiment
Synthomer	Neutral
Zotefoams	Neutral

Summary

Zotefoams beats Synthomer on 12 of the 16 factors compared between the two stocks.

How does Zotefoams compare to Iofina?

Zotefoams (LON:ZTF) and Iofina (LON:IOF) are both small-cap materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

In the previous week, Iofina had 4 more articles in the media than Zotefoams. MarketBeat recorded 4 mentions for Iofina and 0 mentions for Zotefoams. Iofina's average media sentiment score of 0.23 beat Zotefoams' score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Overall Sentiment
Zotefoams	Neutral
Iofina	Neutral

28.9% of Zotefoams shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Zotefoams has a net margin of 13.88% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.18% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	13.88%	18.18%	5.48%
Iofina	11.84%	14.89%	5.18%

Zotefoams currently has a consensus target price of GBX 605, indicating a potential upside of 35.80%. Iofina has a consensus target price of GBX 65, indicating a potential upside of 27.45%. Given Zotefoams' higher possible upside, analysts plainly believe Zotefoams is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£176.29M	1.24	£9.80M	£44.87	9.93
Iofina	£66.52M	1.47	£4.28M	£4.00	12.75

Zotefoams has a beta of 1.243, indicating that its share price is 24% more volatile than the broader market. Comparatively, Iofina has a beta of 0.883, indicating that its share price is 12% less volatile than the broader market.

Summary

Zotefoams beats Iofina on 10 of the 15 factors compared between the two stocks.

Get Zotefoams News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZTF vs. The Competition

Export

Metric	Zotefoams	Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£219.11M	£11.64B	£5.12B	£2.91B
Dividend Yield	1.82%	2.86%	4.68%	6.17%
P/E Ratio	9.93	39.91	26.38	367.33
Price / Sales	1.24	51.13	4,456.33	83,334.32
Price / Cash	18.87	15.22	27.17	27.89
Price / Book	1.81	3.65	9.01	6.99
Net Income	£9.80M	£222.56M	£154.80M	£5.89B
7 Day Performance	2.41%	-0.13%	6.41%	0.75%
1 Month Performance	-3.38%	2.76%	18.44%	3.41%
1 Year Performance	7.35%	16.43%	47.35%	22.85%

Zotefoams Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZTF Zotefoams	N/A	GBX 445.50 +1.3%	GBX 605 +35.8%	+7.3%	£219.11M	£176.29M	9.93	549
VCT Victrex	0.9154 of 5 stars	GBX 812.65 -2.6%	GBX 663.33 -18.4%	+17.8%	£708.03M	£296.40M	N/A	1,109	News Coverage
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350
SYNT Synthomer	2.1427 of 5 stars	GBX 100.60 +0.2%	GBX 119 +18.3%	+64.5%	£164.93M	£1.80B	N/A	4,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:ZTF) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zotefoams (ZTF) Competitors